YTHDF2促进胃癌的进展,并增强化学放射治疗的耐药性
Jian Yang1,2, Yawen Chen3, Yang He3
1The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Drug development research
|April 15, 2024
概括
YTHDF2促进胃癌的进展以及对化疗和放射治疗的抗性. 它的升高水平表明预后不佳,这表明YTHDF2是胃癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在胃癌 (GC) 中YTHDF2的作用仍然存在争议.
- 由于技术挑战,对完全淘汰YTHDF2的研究有限.
- 需要进一步调查以澄清YTHDF2在GC中的临床意义和生物功能.
研究的目的:
- 在GC组织和公共数据库中分析YTHDF2表达水平.
- 研究YTHDF2淘汰对GC进展,入侵和治疗耐药性的影响.
- 阐明GC中YTHDF2的潜在分子机制.
主要方法:
- 在GC患者样本和数据库中分析YTHDF2表达.
- 通过CRISPR-Cas9系统完全淘汰YTHDF2.
- 在体外和体内实验,以评估瘤形成和治疗耐药性.
- 研究YTHDF2对CyclinD1表达和稳定性的影响.
主要成果:
- 在GC组织中YTHDF2水平的增加与负面预后相关.
- 高YTHDF2表达增强GC细胞入侵,特别是在缺氧的情况下,并与HIF-1a相关联.
- YTHDF2促进GC细胞生长,调解CyclinD1表达,并促进对化疗 (DDP,CTX) 和放射治疗的耐药性.
结论:
- YTHDF2通过CyclinD1途径加速GC的进展,并增强化学放射治疗的耐药性.
- YTHDF2作为胃癌的潜在预后生物标志物.
- 向YTHDF2代表了GC的一个有前途的治疗策略.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:17Gastritis-II: Pathophysiology
322
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322